MTD - Mettler-Toledo International Inc.
NYSE
->
Healthcare
->
Diagnostics & Research
Columbus,
United States
Type: Equity
MTD price evolution
MTD
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $70.81 | $70.19 | $69.81 | |
| Short term investments | ||||
| Net receivables | $637.2 | $634.71 | $650.33 | $663.89 |
| Inventory | $375.81 | $366.39 | $373.67 | $385.87 |
| Total current assets | $1198.23 | $1178.31 | $1211.11 | $1230.2 |
| Long term investments | ||||
| Property, plant & equipment | $790.45 | $768.66 | $773.5 | $803.37 |
| Goodwill & intangible assets | $933.51 | $940.19 | $955.54 | |
| Total noncurrent assets | $2070.86 | $2072 | $2125.35 | |
| Total investments | ||||
| Total assets | $3319.83 | $3249.16 | $3283.12 | $3355.55 |
| Current liabilities | ||||
| Accounts payable | $202.86 | $199.46 | $189.45 | $210.41 |
| Deferred revenue | $214.21 | $216.66 | $202.02 | |
| Short long term debt | $311.25 | $183.17 | $192.22 | |
| Total current liabilities | $1184.97 | $1281.18 | $1131.93 | $1181.08 |
| Long term debt | $1891.66 | $1746.64 | $1903.57 | $1888.62 |
| Total noncurrent liabilities | $2120.74 | $2309.9 | $2324.41 | |
| Total debt | $2057.88 | $2086.75 | $2080.84 | |
| Total liabilities | $3474.18 | $3401.93 | $3441.83 | $3505.49 |
| Shareholders' equity | ||||
| Retained earnings | $8121.43 | $7909.92 | $7688.1 | $7510.76 |
| Other shareholder equity | -$327.78 | -$310.37 | -$298.07 | -$319.81 |
| Total shareholder equity | -$152.76 | -$158.72 | -$149.94 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $69.81 | $95.97 | $98.56 | $94.25 |
| Short term investments | ||||
| Net receivables | $663.89 | $709.32 | $647.34 | $593.81 |
| Inventory | $385.87 | $441.69 | $414.54 | $297.61 |
| Total current assets | $1230.2 | $1375.09 | $1269.36 | $1056.9 |
| Long term investments | ||||
| Property, plant & equipment | $803.37 | $892.92 | $799.37 | $798.87 |
| Goodwill & intangible assets | $955.54 | $966.22 | $956.07 | $747.05 |
| Total noncurrent assets | $2125.35 | $2117.31 | $2057.44 | $1757.64 |
| Total investments | ||||
| Total assets | $3355.55 | $3492.39 | $3326.8 | $2814.55 |
| Current liabilities | ||||
| Accounts payable | $210.41 | $252.54 | $272.91 | $175.8 |
| Deferred revenue | $202.02 | $192.76 | $192.65 | $149.11 |
| Short long term debt | $192.22 | $106.05 | $101.13 | $50.32 |
| Total current liabilities | $1181.08 | $1147.73 | $1146.54 | $840.33 |
| Long term debt | $1888.62 | $1908.48 | $1580.81 | $1284.17 |
| Total noncurrent liabilities | $2324.41 | $2319.87 | $2008.84 | $1691.55 |
| Total debt | $2080.84 | $2014.53 | $1681.94 | $1334.49 |
| Total liabilities | $3505.49 | $3467.6 | $3155.38 | $2531.87 |
| Shareholders' equity | ||||
| Retained earnings | $7510.76 | $6726.87 | $5859.27 | $5095.6 |
| Other shareholder equity | -$319.81 | -$227.23 | -$255.22 | -$334.93 |
| Total shareholder equity | -$149.94 | $24.79 | $171.42 | $282.68 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $954.53 | $925.95 | $934.99 | |
| Cost of revenue | $377.82 | $383.35 | ||
| Gross Profit | $572.47 | $548.13 | $551.64 | |
| Operating activities | ||||
| Research & development | $46.41 | $46.44 | ||
| Selling, general & administrative | $234.39 | $223.43 | ||
| Total operating expenses | $292.29 | $308.35 | $303.57 | |
| Operating income | $239.78 | $248.06 | ||
| Income from continuing operations | ||||
| EBIT | $239.78 | $252.21 | ||
| Income tax expense | $47.44 | $43.04 | $47.76 | |
| Interest expense | -$18.6 | $19.23 | $19.66 | |
| Net income | ||||
| Net income | $211.52 | $177.51 | $184.79 | |
| Income (for common shares) | $177.51 | $184.79 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3788.31 | $3919.71 | $3717.93 | $3085.18 |
| Cost of revenue | $1547.02 | $1611.67 | $1546.38 | $1284.15 |
| Gross Profit | $2241.29 | $2308.04 | $2171.55 | $1801.03 |
| Operating activities | ||||
| Research & development | $185.28 | $177.12 | $169.77 | $140.1 |
| Selling, general & administrative | $904.11 | $938.46 | $943.98 | $820.22 |
| Total operating expenses | $1194.34 | $1191.38 | $1182.06 | $1027.5 |
| Operating income | $1046.95 | $1116.66 | $989.5 | $773.53 |
| Income from continuing operations | ||||
| EBIT | $1051.09 | $1125.98 | $992.6 | $787.36 |
| Income tax expense | $184.95 | $198.09 | $180.38 | $146 |
| Interest expense | $77.37 | $55.39 | $43.24 | $38.62 |
| Net income | ||||
| Net income | $788.78 | $872.5 | $768.99 | $602.74 |
| Income (for common shares) | $788.78 | $872.5 | $768.99 | $602.74 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $221.81 | $177.51 | $184.79 | |
| Operating activities | ||||
| Depreciation | $30.53 | $30.75 | $30.62 | |
| Business acquisitions & disposals | -$1.47 | -$1 | -$5.2 | |
| Stock-based compensation | $4.54 | $4.72 | $5.48 | |
| Total cash flows from operations | $257.51 | $189.99 | $281.5 | |
| Investing activities | ||||
| Capital expenditures | -$23.14 | -$17.39 | -$32.25 | |
| Investments | $6.09 | |||
| Total cash flows from investing | -$68.41 | -$21.83 | -$8.94 | -$35.5 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$206.19 | -$210.67 | -$176 | |
| Net borrowings | -$26.2 | $31.58 | -$72.97 | |
| Total cash flows from financing | -$632.28 | -$234.3 | -$179.09 | -$248.97 |
| Effect of exchange rate | $0.3 | -$0.75 | -$1.58 | $3.1 |
| Change in cash and equivalents | $1.77 | $0.62 | $0.38 | $0.13 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $788.78 | $872.5 | $768.99 | $602.74 |
| Operating activities | ||||
| Depreciation | $121.16 | $113.02 | $108.06 | $98.71 |
| Business acquisitions & disposals | -$5.81 | -$37.95 | -$220.86 | -$6.24 |
| Stock-based compensation | $17.93 | $19.66 | $19.59 | $18.69 |
| Total cash flows from operations | $965.87 | $859.07 | $908.83 | $724.7 |
| Investing activities | ||||
| Capital expenditures | -$104.49 | -$120.84 | -$103.93 | -$89.39 |
| Investments | $6.09 | $29.67 | ||
| Total cash flows from investing | -$131.69 | -$139.4 | -$314.11 | -$100.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$880.77 | -$1066.78 | -$979.53 | -$748.28 |
| Net borrowings | $29.77 | $359.86 | $391.97 | $5.17 |
| Total cash flows from financing | -$859.59 | -$716.04 | -$590.55 | -$743.91 |
| Effect of exchange rate | -$0.75 | -$6.23 | $0.14 | $6.04 |
| Change in cash and equivalents | -$26.16 | -$2.6 | $4.31 | -$113.53 |
News
Fundamentals
| Market cap | $27.90B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 21.68M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 1.28% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -23.38 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.01 |
| Quick ratio | 0.69 |